# FDA Inspection 1262032 - CSL Plasma Inc. - February 13, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/csl-plasma-inc/2964b087-a8df-486e-b976-b3a72ac0cba4
Source feed: FDA_Inspections

> FDA Inspection 1262032 for CSL Plasma Inc. on February 13, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1262032
- Company Name: CSL Plasma Inc.
- Inspection Date: 2025-02-13
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1262032 - 2025-02-13](https://www.globalkeysolutions.net/records/fda_inspections/csl-plasma-inc/f2e27948-186a-4bc2-b237-eafa77f59eaf)
- [FDA Inspection 1097594 - 2019-07-18](https://www.globalkeysolutions.net/records/fda_inspections/csl-plasma-inc/1d81e566-0976-47ce-b48b-0bdaa75b71ef)

Company: https://www.globalkeysolutions.net/companies/csl-plasma-inc/9472157e-a1bb-4798-91bd-eecd25b4b81e

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d